GlassScriptPhysician profile
Bruce Frank Weber
NPI 1609870591
$5,290.89
in general payments reported to CMS, 2019-2025
48 companies · $820 in 2025
The $820 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,171 · 2020: $190 · 2021: $578 · 2022: $861 · 2023: $283 · 2024: $387 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk As | $1,601.00 | 2019 | |
| Novo Nordisk INC | $422.83 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $348.85 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $275.44 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Pfizer INC. | $238.69 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $224.34 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $219.62 | 2019-2025 | Spravato, Xarelto |
| Amgen INC. | $186.58 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $173.26 | 2021-2025 | Freestyle Libre 3 |
| Insulet Corporation | $122.88 | 2019-2025 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $112.92 | 2019-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $104.40 | 2019-2025 | Eliquis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $98.66 | 2022-2025 | Caplyta |
| Glaxosmithkline, LLC. | $96.47 | 2019-2025 | Trelegy Ellipta |
| Biogen, INC. | $76.29 | 2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.